Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Preserved Trial.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of heart failure"
DOI: 10.1002/ejhf.2857
Abstract: BACKGROUND In the EMPEROR-Preserved trial, empagliflozin improved clinical outcomes of patients with heart failure with preserved ejection fraction. In this pre-specified analysis, we aim to study the effect of empagliflozin on cardiovascular and kidney outcomes… read more here.
Keywords: emperor preserved; heart failure; without ckd; kidney ... See more keywords
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.05.057
Abstract: BACKGROUND The optimal revascularization strategy for patients with left main coronary artery disease (LMCAD) and chronic kidney disease (CKD) remains unclear. OBJECTIVES This study investigated the comparative effectiveness of percutaneous coronary intervention (PCI) versus coronary… read more here.
Keywords: left main; trial; without ckd; cabg patients ... See more keywords
COMPARATIVE EFFICACY OF LOSARTAN MONOTHERAPY AND ITS COMBINATIONS IN IGA NEPHROPATHY-RELATED HYPERTENSION: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0001116996.56605.36
Abstract: Objective: Arterial hypertension and dyslipidemia are the main causes of accelerated atherosclerosis in chronic kidney disease (CKD). In CKD, dyslipidemia is more complex than in non-CKD subjects. The aim of this study was to analyze… read more here.
Keywords: ckd; without ckd; hdl; hypertension ... See more keywords
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease.
Sign Up to like & getrecommendations! Published in 2023 at "Nephron"
DOI: 10.1159/000528080
Abstract: BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is suggested as a risk factor for chronic kidney disease (CKD). The incidence of NAFLD is rising globally in parallel to the increasing incidences of obesity and type 2… read more here.
Keywords: patients type; nonalcoholic fatty; without ckd; disease ... See more keywords
Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006-2020.
Sign Up to like & getrecommendations! Published in 2022 at "Diabetes care"
DOI: 10.2337/dc22-0224
Abstract: OBJECTIVE To evaluate trends in antidiabetic medication initiation patterns among patients with type 2 diabetes mellitus (T2DM) with and without chronic kidney disease (CKD). RESEARCH DESIGN AND METHODS A retrospective cohort study using the UK… read more here.
Keywords: patients type; without ckd; without chronic; type diabetes ... See more keywords